Aditxt announced amendments to its merger agreement with Evofem Biosciences on September 6, 2024. The key changes include adjusting the Third Parent Equity Investment deadline from September 6 to September 30, 2024, while modifying the investment amount from $2 million to $1.5 million. Additionally, the Fourth Parent Equity Investment deadline has been extended from September 30 to October 31, 2024, with the amount adjusted from $1 million to $1.5 million.The amendments are part of the broader merger plan where Evofem will become a wholly-owned subsidiary of Aditxt through a merger with Adifem (formerly Adicure), a Delaware corporation and Aditxt's wholly owned subsidiary. The transaction remains subject to various conditions, including stockholder approval and regulatory clearances.The merger agreement previously included a series of planned equity investments, with Aditxt committing to purchase Evofem's Series F-1 Preferred Stock in multiple tranches. The initial $500,000 investment was scheduled for July 12, 2024, followed by a second $500,000 investment due on August 9, 2024.

Aditxt announced amendments to its merger agreement with Evofem Biosciences on September 6, 2024. The key changes include adjusting the Third Parent Equity Investment deadline from September 6 to September 30, 2024, while modifying the investment amount from $2 million to $1.5 million. Additionally, the Fourth Parent Equity Investment deadline has been extended from September 30 to October 31, 2024, with the amount adjusted from $1 million to $1.5 million.The amendments are part of the broader merger plan where Evofem will become a wholly-owned subsidiary of Aditxt through a merger with Adifem (formerly Adicure), a Delaware corporation and Aditxt's wholly owned subsidiary. The transaction remains subject to various conditions, including stockholder approval and regulatory clearances.The merger agreement previously included a series of planned equity investments, with Aditxt committing to purchase Evofem's Series F-1 Preferred Stock in multiple tranches. The initial $500,000 investment was scheduled for July 12, 2024, followed by a second $500,000 investment due on August 9, 2024.